BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33131108)

  • 1. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission.
    Narula N; Aruljothy A; Alshahrani AA; Fadida M; Al-Saedi M; Marshall JK; Rubin DT; Christensen B
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1676-1682. PubMed ID: 33131108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission.
    Wang H; Fewings I; Bornman L; Shadbolt B; Fadia M; Subramaniam K
    J Clin Gastroenterol; 2023 May-Jun 01; 57(5):494-500. PubMed ID: 35220375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Yoon H; Jangi S; Dulai PS; Boland BS; Prokop LJ; Jairath V; Feagan BG; Sandborn WJ; Singh S
    Gastroenterology; 2020 Oct; 159(4):1262-1275.e7. PubMed ID: 32585306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse.
    Park J; Kang SJ; Yoon H; Park J; Oh HJ; Na HY; Lee HS; Shin CM; Park YS; Kim N; Lee DH
    Inflamm Bowel Dis; 2022 Nov; 28(11):1709-1716. PubMed ID: 35016209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing.
    Jangi S; Yoon H; Dulai PS; Valasek M; Boland BS; Jairath V; Feagan BG; Sandborn WJ; Singh S
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1008-1016. PubMed ID: 33119168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.
    Calafat M; Lobatón T; Hernández-Gallego A; Mañosa M; Torres P; Cañete F; Cabré E; Ojanguren I; Domènech E
    Dig Liver Dis; 2017 Dec; 49(12):1327-1331. PubMed ID: 28958412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission.
    Cushing KC; Tan W; Alpers DH; Deshpande V; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2020 Feb; 51(3):347-355. PubMed ID: 31696961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
    Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
    Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
    Fron C; Pierry C; Poullenot F; Chabrun E; Subtil C; Capdepont M; Zerbib F; Belleannée G; Laharie D
    Dig Liver Dis; 2016 Jul; 48(7):734-9. PubMed ID: 27052254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
    Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
    Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
    World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited endoscopic mucosal inflammation on equivalent to Mayo endoscopic subscore of 0 unaffect clinical relapse of ulcerative colitis.
    Shimodaira Y; Watanabe K; Fukuda S; Watanabe N; Koizumi S; Matsuhashi T; Onochi K; Iijima K
    Scand J Gastroenterol; 2022 Feb; 57(2):165-168. PubMed ID: 34663142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
    Pandey A; Achrafie L; Kodjamanova P; Tencer T; Kumar J
    Curr Med Res Opin; 2022 Sep; 38(9):1531-1541. PubMed ID: 35608153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis.
    Bessissow T; Kron CM; Marcus V; Lemieux C; Laneuville J; Afif W; Wild G; Lakatos PL; Brassard P; Bitton A
    Am J Gastroenterol; 2022 Oct; 117(10):1632-1638. PubMed ID: 35862833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
    Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
    World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
    Seong G; Song JH; Kim JE; Kim TJ; Kim ER; Hong SN; Chang DK; Kim SH; Ha SY; Kim YH
    Inflamm Bowel Dis; 2023 Feb; 29(2):238-244. PubMed ID: 35396998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.
    Bryant RV; Burger DC; Delo J; Walsh AJ; Thomas S; von Herbay A; Buchel OC; White L; Brain O; Keshav S; Warren BF; Travis SP
    Gut; 2016 Mar; 65(3):408-14. PubMed ID: 25986946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis.
    Jangi S; Holmer AK; Dulai PS; Boland B; Valasek M; Jairath V; Feagan BG; Sandborn WJ; Singh S
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):e750-e760. PubMed ID: 33556578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
    Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H
    Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.